THE SAINSBURY LABORATORY

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“No material uncertainties that may cast significant doubt about the ability of the charity to continue as a going concern have been identified by the Trustees and therefore in their opinion it is appropriate to prepare the financial statements on a going concern basis.”

Group structure

1. THE SAINSBURY LABORATORY · parent
   1. Plant Science Innovations Limited (PSI) 100% · UK

Significant events

• “TSL has achieved significant advances in plant science research, with 73 new publications (including preprints) showcasing breakthroughs in plant immunity, microbial pathogenesis, and advances in new technologies such as Al-based modelling and bioengineering disease resistance.”
• “TSL has also launched new research directions. A newly established research group are applying single cell technologies and developing novel strategies to explore plant cell states and their role in immunity.”
• “TSL Ventures has been launched to provide in-house support for new company creation, protect intellectual property and train entrepreneurial scientists.”
• “TSL/John Innes Centre spinout company Norfolk Plant Sciences successfully commercialized its high-anthocyanin purple tomato in the United States, sold as 'Empress' through a partnership with Red Sun Farms Ltd. Over 100,000 clamshells were sold in the 2024 season, with more than 35 licensed sellers confirmed for 2025.”
• “TSL received exceptional recognition this year, earning acclaim for its leadership, scientific impact, and pioneering research in plant immunity. Most notably, the institute celebrated its 2nd Wolf Prize Laureate in Agriculture, jointly awarded to TSL senior group leader and two former scientific advisors for their 'groundbreaking discoveries of the immune system and disease resistance in plants.'”
• “TSL and the John Innes Centre have begun building a new ~£400 million joint facility, funded through a combination of private and charitable sources alongside the UKRI Infrastructure Fund. Scheduled for completion in 2031, the facility will enable TSL to pursue cutting-edge interdisciplinary research in support of its Healthy Plant, Healthy People, Healthy Planet (HP3) vision.”
• “On the 15th August 2025 TSL exercised a share warrant entitling it to make a further investment of £100,000 into Norfolk Plant Sciences Ltd.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +17.3%

  £10,354,649 → £12,148,459

• Cash

  +32.3%

  £6,559,821 → £8,681,796

• Net assets

  +14.7%

  £12,915,156 → £14,812,875

• Employees

  +3.7%

  82 → 85

• Wages

  +12.4%

  £4,195,676 → £4,717,107

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers